Quick Answer
Cordyceps Sunshine Biotech Holdings Co., Ltd. reported Research And Development Expense of $118.4 thousand for the year ending 2022.
- Cordyceps Sunshine Biotech Holdings Co., Ltd. showed an increase of +372.8% in Research And Development Expense from 2021 to 2022.
- This data is from Cordyceps Sunshine Biotech Holdings Co., Ltd.'s annual report (Form 10-K), filed with the SEC on June 13, 2025.
- XBRL data for this metric is available from 2021 to 2022 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2022: $118.4 thousand | Fiscal year 2021: $25.1 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: